Skip to main content
Clinical Trials/JPRN-UMIN000030448
JPRN-UMIN000030448
Not Yet Recruiting
N/A

ow-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4 - ESWT-CKD

Osaka University Graduate School of Medicine0 sites66 target enrollmentApril 1, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Osaka University Graduate School of Medicine
Enrollment
66
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with a local skin infection at the contact site with the applicator Patients with bleeding tendency Patients with urolithiasis or kidney stones Patients with hydronephrosis Patients with active pyelonephritis Patients with cancer Patients treated with steroids or immunosuppressants Patients who is expected to introduce dialysis within 12 weeks Polycystic kidney disease patients Patients with renal morphological abnormality Patients who received kidney transplantation Dialysis patients (HD, PD) Patients whose renal blood flow cannot be evaluated Objects considered by the attending physician as inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials